Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Editas Medicine (EDIT) over the last 11 years, with Q3 2025 value amounting to -$1.6 billion.

  • Editas Medicine's Retained Earnings fell 1404.27% to -$1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.6 billion, marking a year-over-year decrease of 1404.27%. This contributed to the annual value of -$1.5 billion for FY2024, which is 1925.47% down from last year.
  • As of Q3 2025, Editas Medicine's Retained Earnings stood at -$1.6 billion, which was down 1404.27% from -$1.6 billion recorded in Q2 2025.
  • In the past 5 years, Editas Medicine's Retained Earnings ranged from a high of -$721.9 million in Q1 2021 and a low of -$1.6 billion during Q3 2025
  • Its 5-year average for Retained Earnings is -$1.2 billion, with a median of -$1.2 billion in 2023.
  • In the last 5 years, Editas Medicine's Retained Earnings tumbled by 3544.05% in 2021 and then crashed by 1404.27% in 2025.
  • Editas Medicine's Retained Earnings (Quarter) stood at -$857.7 million in 2021, then fell by 25.7% to -$1.1 billion in 2022, then decreased by 14.21% to -$1.2 billion in 2023, then fell by 19.25% to -$1.5 billion in 2024, then dropped by 10.52% to -$1.6 billion in 2025.
  • Its Retained Earnings stands at -$1.6 billion for Q3 2025, versus -$1.6 billion for Q2 2025 and -$1.5 billion for Q1 2025.